Tolerability of Palmitoylethanolamide in a Pediatric Population Suffering from Migraine: A Pilot Study

BACKGROUND: Palmitoylethanolamide (PEA) is emerging as a new therapeutic approach in pain and inflammatory conditions, and it has been evaluated in studies on various painful diseases. The aim of this open-label study was to evaluate the efficacy of ultramicronized PEA (umPEA) in the prophylactic tr...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Pain Res Manag
Autori principali: Papetti, Laura, Sforza, Giorgia, Tullo, Giulia, Alaimo di Loro, Pierfrancesco, Moavero, Romina, Ursitti, Fabiana, Ferilli, Michela Ada Noris, Tarantino, Samuela, Vigevano, Federico, Valeriani, Massimiliano
Natura: Artigo
Lingua:Inglês
Pubblicazione: Hindawi 2020
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7196162/
https://ncbi.nlm.nih.gov/pubmed/32377286
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/3938640
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi